Related Experiment Video

Updated: Jun 1, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

HIV-associated Pneumocystis pneumonia

Laurence Huang1, Adithya Cattamanchi, J Lucian Davis

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California 94110, USA. lhuang@php.ucsf.edu

Proceedings of the American Thoracic Society
|June 10, 2011
PubMed

Insights

Despite advances, gaps remain in understanding Pneumocystis pneumonia (PCP) in HIV/AIDS patients. Research is ongoing to improve diagnosis, treatment, and epidemiology of this opportunistic infection.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Mycology

Background:

  • Significant knowledge gaps persist regarding Pneumocystis pneumonia (PCP) in Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) patients.
  • Pneumocystis, a fungus, has an incompletely understood reservoir, transmission, and pathogenesis, despite being host-specific.
  • PCP is a common AIDS-defining illness in the US and Europe, but global epidemiological data, especially from high HIV burden regions, are scarce.

Purpose of the Study:

  • To address critical knowledge gaps in the pathogenesis, epidemiology, diagnosis, and management of HIV-associated PCP.
  • To review recent advancements and ongoing research within the International HIV-associated Opportunistic Pneumonias (IHOP) study and the Longitudinal Studies of HIV-associated Lung Infections and Complications (Lung HIV).

Main Methods:

  • Review of recent clinical and translational research findings.
  • Analysis of data from the IHOP and Lung HIV studies.
  • Discussion of diagnostic challenges and emerging treatment concerns.

Main Results:

  • PCP remains a frequent opportunistic infection in HIV/AIDS patients, necessitating further research.
  • Current diagnostic methods like bronchoscopy with bronchoalveolar lavage are invasive; promising non-invasive tests require validation.
  • Emerging concerns regarding trimethoprim-sulfamethoxazole drug resistance highlight the need for alternative strategies.

Conclusions:

  • Continued research is crucial to fully understand and manage HIV-associated PCP.
  • Validation of non-invasive diagnostic tools and monitoring for drug resistance are key priorities.
  • International collaboration and comprehensive studies like IHOP are vital for advancing care and knowledge globally.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...